blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP2364306

EP2364306 - Pyridine and pyrimidine derivatives as phosphodiesterase 10 inhibitors [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  28.02.2014
Database last updated on 02.11.2024
Most recent event   Tooltip04.09.2015Lapse of the patent in a contracting state
New state(s): MT		published on 07.10.2015  [2015/41]
Applicant(s)For all designated states
Amgen Inc.
One Amgen Center Drive
Thousand Oaks, CA 91320-1799 / US
[2011/37]
Inventor(s)01 / ALLEN, Jennifer R.
139 Via Aldea
Newbury Park California 91320 / US
02 / BISWAS, Kaustav
26003 B. Alizia Canyon Dr.
Calabasas California 91302 / US
03 / CHAVEZ, Frank, Jr.
1111 San Clemente Way
Camarillo California 93010 / US
04 / CHEN, Ning
2342 Gillingham Circle
Thousand Oaks California 91362 / US
05 / DEMORIN, Frenel Fils
3023 Mulberry Circle
Thousand Oaks California 91360 / US
06 / FALSEY, James R.
4943 Hollyglen Ct.
Moorpark California 93021 / US
07 / FROHN, Mike
2808 Cedar Wood Place
Thousand Oaks California 91362 / US
08 / HARRINGTON, Paul
6134 Paseo Encantada
Camarillo California 93012 / US
09 / HORNE, Dan
125 Parkside Dr.
Simi Valley California 93065 / US
10 / HU, Essa
3824 Fountain Street
Camarillo California 93012 / US
11 / KALLER, Matthew R.
484 Jones Street
Ventura California 93003 / US
12 / KUNZ, Roxanne
451 San Vicente Blvd. Apt. 11
Santa Monica California 90402 / US
13 / MONENSCHEIN, Holger
711 Hunt Circle
Camarillo California 93012 / US
14 / NGUYEN, Tom
468 Calle Veracruz
Newbury Park California 91320 / US
15 / PICKRELL, Alex
30948 Minute Man Way
Westlake Village California 91361 / US
16 / REICHELT, Andreas
6625 Pinnacle Way
Moorpark California 93021 / US
17 / RUMFELT, Shannon
2766 Wendell Street
Camarillo California 93010 / US
18 / RZASA, Rob
160 Kennedy Ave
Ventura California 93003 / US
19 / SHAM, Kelvin
3111 La Casa Court
Thousand Oaks California 91362 / US
20 / YAO, Guomin
5332 San Francesca Drive
Camarillo CA 93012 / US
 [2011/37]
Representative(s)Grünecker Patent- und Rechtsanwälte PartG mbB
Leopoldstrasse 4
80802 München / DE
[N/P]
Former [2013/17]Grünecker, Kinkeldey, Stockmair & Schwanhäusser
Leopoldstrasse 4
80802 München / DE
Former [2011/37]Grünecker, Kinkeldey, Stockmair & Schwanhäusser Anwaltssozietät
Leopoldstrasse 4
80802 München / DE
Application number, filing date09752706.316.11.2009
WO2009US64643
Priority number, dateUS20080114595P14.11.2008         Original published format: US 114595 P
US20090166215P02.04.2009         Original published format: US 166215 P
[2011/37]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2010057126
Date:20.05.2010
Language:EN
[2010/20]
Type: A1 Application with search report 
No.:EP2364306
Date:14.09.2011
Language:EN
The application published by WIPO in one of the EPO official languages on 20.05.2010 takes the place of the publication of the European patent application.
[2011/37]
Type: B1 Patent specification 
No.:EP2364306
Date:24.04.2013
Language:EN
[2013/17]
Search report(s)International search report - published on:EP20.05.2010
ClassificationIPC:C07D401/12, C07D401/14, C07D417/12, C07D471/04, C07D473/00, A61K31/4184, A61P25/18, A61P3/00
[2011/37]
CPC:
A61P3/00 (EP); C07D401/12 (EP,KR,US); C07D413/14 (US);
A61K31/4439 (KR); A61P25/00 (EP); A61P25/14 (EP);
A61P25/16 (EP); A61P25/18 (EP); A61P25/24 (EP);
A61P25/28 (EP); A61P25/30 (EP); A61P43/00 (EP);
C07D401/10 (KR); C07D401/14 (EP,US); C07D417/12 (EP,US);
C07D471/04 (EP,US); C07D473/00 (EP,US) (-)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   SE,   SI,   SK,   SM,   TR [2013/17]
Extension statesAL09.06.2011
BA09.06.2011
RS09.06.2011
TitleGerman:PYRIDIN- UND PYRIMIDINDERIVATE ALS PHOSPHODIESTERASE-10-INHIBITOREN[2011/37]
English:Pyridine and pyrimidine derivatives as phosphodiesterase 10 inhibitors[2011/37]
French:Derives de pyridine et de pyrimidine comme inhibiteurs de phosphodiesterase 10[2011/37]
Entry into regional phase09.06.2011National basic fee paid 
09.06.2011Designation fee(s) paid 
09.06.2011Examination fee paid 
Examination procedure09.06.2011Examination requested  [2011/37]
30.01.2012Amendment by applicant (claims and/or description)
08.06.2012Despatch of a communication from the examining division (Time limit: M04)
29.06.2012Reply to a communication from the examining division
30.07.2012Communication of intention to grant the patent
22.10.2012Disapproval of the communication of intention to grant the patent by the applicant or resumption of examination proceedings by the EPO
12.11.2012Communication of intention to grant the patent
13.03.2013Fee for grant paid
13.03.2013Fee for publishing/printing paid
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  08.06.2012
Opposition(s)27.01.2014No opposition filed within time limit [2014/14]
Fees paidRenewal fee
14.11.2011Renewal fee patent year 03
13.11.2012Renewal fee patent year 04
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU16.11.2009
AT24.04.2013
BE24.04.2013
CY24.04.2013
CZ24.04.2013
DK24.04.2013
EE24.04.2013
FI24.04.2013
HR24.04.2013
LT24.04.2013
LV24.04.2013
MC24.04.2013
MK24.04.2013
MT24.04.2013
NL24.04.2013
PL24.04.2013
RO24.04.2013
SE24.04.2013
SI24.04.2013
SK24.04.2013
SM24.04.2013
TR24.04.2013
BG24.07.2013
NO24.07.2013
GR25.07.2013
IS24.08.2013
PT26.08.2013
IE16.11.2013
LU16.11.2013
[2015/41]
Former [2015/34]HU16.11.2009
AT24.04.2013
BE24.04.2013
CY24.04.2013
CZ24.04.2013
DK24.04.2013
EE24.04.2013
FI24.04.2013
HR24.04.2013
LT24.04.2013
LV24.04.2013
MC24.04.2013
MK24.04.2013
NL24.04.2013
PL24.04.2013
RO24.04.2013
SE24.04.2013
SI24.04.2013
SK24.04.2013
SM24.04.2013
TR24.04.2013
BG24.07.2013
NO24.07.2013
GR25.07.2013
IS24.08.2013
PT26.08.2013
IE16.11.2013
LU16.11.2013
Former [2015/32]AT24.04.2013
BE24.04.2013
CY24.04.2013
CZ24.04.2013
DK24.04.2013
EE24.04.2013
FI24.04.2013
HR24.04.2013
LT24.04.2013
LV24.04.2013
MC24.04.2013
MK24.04.2013
NL24.04.2013
PL24.04.2013
RO24.04.2013
SE24.04.2013
SI24.04.2013
SK24.04.2013
SM24.04.2013
TR24.04.2013
BG24.07.2013
NO24.07.2013
GR25.07.2013
IS24.08.2013
PT26.08.2013
IE16.11.2013
Former [2015/24]AT24.04.2013
BE24.04.2013
CY24.04.2013
CZ24.04.2013
DK24.04.2013
EE24.04.2013
FI24.04.2013
HR24.04.2013
LT24.04.2013
LV24.04.2013
MC24.04.2013
NL24.04.2013
PL24.04.2013
RO24.04.2013
SE24.04.2013
SI24.04.2013
SK24.04.2013
SM24.04.2013
BG24.07.2013
NO24.07.2013
GR25.07.2013
IS24.08.2013
PT26.08.2013
IE16.11.2013
Former [2014/48]AT24.04.2013
BE24.04.2013
CY24.04.2013
CZ24.04.2013
DK24.04.2013
EE24.04.2013
FI24.04.2013
HR24.04.2013
LT24.04.2013
LV24.04.2013
MC24.04.2013
NL24.04.2013
PL24.04.2013
RO24.04.2013
SE24.04.2013
SI24.04.2013
SK24.04.2013
BG24.07.2013
NO24.07.2013
GR25.07.2013
IS24.08.2013
PT26.08.2013
IE16.11.2013
Former [2014/33]AT24.04.2013
BE24.04.2013
CY24.04.2013
CZ24.04.2013
DK24.04.2013
EE24.04.2013
FI24.04.2013
HR24.04.2013
LT24.04.2013
LV24.04.2013
MC24.04.2013
NL24.04.2013
PL24.04.2013
RO24.04.2013
SE24.04.2013
SI24.04.2013
SK24.04.2013
BG24.07.2013
NO24.07.2013
GR25.07.2013
IS24.08.2013
PT26.08.2013
Former [2014/14]AT24.04.2013
BE24.04.2013
CY24.04.2013
CZ24.04.2013
DK24.04.2013
EE24.04.2013
FI24.04.2013
HR24.04.2013
LT24.04.2013
LV24.04.2013
NL24.04.2013
PL24.04.2013
RO24.04.2013
SE24.04.2013
SI24.04.2013
SK24.04.2013
BG24.07.2013
NO24.07.2013
GR25.07.2013
IS24.08.2013
PT26.08.2013
Former [2014/11]AT24.04.2013
BE24.04.2013
CY24.04.2013
CZ24.04.2013
DK24.04.2013
EE24.04.2013
FI24.04.2013
HR24.04.2013
LT24.04.2013
LV24.04.2013
PL24.04.2013
RO24.04.2013
SE24.04.2013
SI24.04.2013
SK24.04.2013
BG24.07.2013
NO24.07.2013
GR25.07.2013
IS24.08.2013
PT26.08.2013
Former [2014/10]AT24.04.2013
BE24.04.2013
CY24.04.2013
CZ24.04.2013
DK24.04.2013
EE24.04.2013
FI24.04.2013
HR24.04.2013
LT24.04.2013
LV24.04.2013
PL24.04.2013
SE24.04.2013
SI24.04.2013
SK24.04.2013
BG24.07.2013
NO24.07.2013
GR25.07.2013
IS24.08.2013
PT26.08.2013
Former [2014/09]AT24.04.2013
BE24.04.2013
CY24.04.2013
DK24.04.2013
EE24.04.2013
FI24.04.2013
HR24.04.2013
LT24.04.2013
LV24.04.2013
PL24.04.2013
SE24.04.2013
SI24.04.2013
BG24.07.2013
NO24.07.2013
GR25.07.2013
IS24.08.2013
PT26.08.2013
Former [2013/52]AT24.04.2013
BE24.04.2013
CY24.04.2013
FI24.04.2013
HR24.04.2013
LT24.04.2013
LV24.04.2013
PL24.04.2013
SE24.04.2013
SI24.04.2013
BG24.07.2013
NO24.07.2013
GR25.07.2013
IS24.08.2013
PT26.08.2013
Former [2013/51]AT24.04.2013
BE24.04.2013
FI24.04.2013
HR24.04.2013
LT24.04.2013
LV24.04.2013
PL24.04.2013
SE24.04.2013
SI24.04.2013
BG24.07.2013
NO24.07.2013
GR25.07.2013
IS24.08.2013
PT26.08.2013
Former [2013/50]AT24.04.2013
BE24.04.2013
FI24.04.2013
LT24.04.2013
LV24.04.2013
PL24.04.2013
SE24.04.2013
SI24.04.2013
BG24.07.2013
NO24.07.2013
GR25.07.2013
IS24.08.2013
PT26.08.2013
Former [2013/49]AT24.04.2013
BE24.04.2013
FI24.04.2013
LT24.04.2013
SE24.04.2013
SI24.04.2013
NO24.07.2013
GR25.07.2013
IS24.08.2013
PT26.08.2013
Former [2013/48]AT24.04.2013
LT24.04.2013
NO24.07.2013
IS24.08.2013
PT26.08.2013
Former [2013/47]LT24.04.2013
NO24.07.2013
PT26.08.2013
Cited inInternational search[X]DE10344223  (MERCK PATENT GMBH [DE]) [X] 1-28 * see example at the bottom of page 30; pages 1-2 *;
 [X]WO2005042520  (MERCK PATENT GMBH [DE], et al) [X] 1-28 * examples 30,37 *;
 [A]US2007155779  (VERHOEST PATRICK R [US], et al) [A] 1-28 * the whole document *;
 [X]WO2007100646  (AMGEN INC [US], et al) [X] 1-28 * examples 93,103,105 *;
 [A]  - KEHLER J ET AL, "The potential therapeutic use of phosphodiesterase 10 inhibitors", EXPERT OPINION ON THERAPEUTIC PATENTS, INFORMA HEALTHCARE, GB, (20070201), vol. 17, no. 2, ISSN 1354-3776, pages 147 - 158, XP002529529 [A] 1-28 * the whole document *

DOI:   http://dx.doi.org/10.1517/13543776.17.12.147
by applicantDE10344223
 WO2005042520
 US2007155779
 WO2007100646
    - FUJISHIGE ET AL., J. BIOL. CHEM., (1999), vol. 274, pages 18438 - 18445
    - LOUGHNEY ET AL., GENE, (1999), vol. 234, pages 109 - 117
    - SODERLING ET AL., PROC. NATL. ACAD. SCI. USA, (1999), vol. 96, pages 7071 - 7076
    - KEHLER J ET AL., EXPERT OPINION ON THERAPEUTIC PATENTS, INFORMA HEALTHCARE, (20070201), vol. 17, no. 2, pages 147 - 158
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.